Advertisement
Screener

Nuo Therapeutics, Inc. (AURX) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.9 / 5 stars · 32/56 Roast Me

Nuo Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

Nuo Therapeutics, Inc. (AURX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-30

  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2021-03-31 was 0.00%.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.00%.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2025-12-310.00%
10-K · filed 2026-03-30
2024-12-310.00%
10-K · filed 2026-03-30
2024-09-300.00%
10-Q · filed 2024-11-12
2023-12-310.00%
10-K · filed 2025-04-01
2023-09-300.00%
10-Q · filed 2024-11-12
2023-03-310.00%
10-Q · filed 2023-05-15
2022-12-310.00%
10-K · filed 2024-04-19
2022-09-300.00%
10-Q · filed 2022-11-04
2022-06-300.00%
10-Q · filed 2023-08-14
2022-03-310.00%
10-Q · filed 2022-05-16
2021-12-310.00%
10-K · filed 2023-04-17
2021-09-300.00%
10-Q · filed 2022-11-04
2021-06-300.00%
10-Q/A · filed 2022-08-10
2021-03-310.00%
10-Q · filed 2022-05-16
2020-12-310.00%
10-K · filed 2022-04-15
2020-09-300.00%
10-Q · filed 2022-11-04
2019-03-310.00%
10-Q · filed 2019-05-20
2015-06-300.00%
10-Q · filed 2015-08-13
2015-03-310.00%
10-Q · filed 2015-05-14
2014-12-310.00%
10-K · filed 2015-03-31
2014-06-300.00%
10-Q · filed 2015-08-13
2014-03-310.00%
10-Q · filed 2015-05-14
2013-12-310.00%
10-K · filed 2015-03-31
2012-12-310.00%
10-K · filed 2014-03-31
2011-12-310.00%
10-K · filed 2013-03-18